Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Hepatocellular × Anidulafungin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Sorafenib 16 lenvatinib 15 Hepatectomy 15 Blood Specimen Collection 10 Immune Checkpoint Inhibitors 9 Liver Transplantation 7 atezolizumab 6 Surgical Procedures, Operative 6 gadolinium ethoxybenzyl DTPA 5 Radiofrequency Ablation 5 Observation 5 Bevacizumab 5 regorafenib 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 tislelizumab 3 sintilimab 3 donafenib 3 camrelizumab 3 Polymerase Chain Reaction 3 Neoadjuvant Therapy 3 Mass Spectrometry 3 Immunohistochemistry 3 Angiogenesis Inhibitors 3 toripalimab 2 spartalizumab 2 pembrolizumab 2 entecavir 2 adefovir dipivoxil 2 Tenofovir 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

40,110 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡